Demência com corpos de Lewy

abordagem clínica e terapêutica

Autores

  • Antônio Lúcio Teixeira-Jr Médico Neurologista e Psiquiatra. Professor Adjunto do Departamento de Clínica Médica da Faculdade de Medicina da Universidade Federal de Minas Gerais (UFMG)
  • Francisco Cardoso Chefe do Serviço de Neurologia do Hospital das Clínicas da UFMG. Professor Adjunto do Departamento de Clínica Médica da Faculdade de Medicina da UFMG.

DOI:

https://doi.org/10.34024/rnc.2005.v13.8842

Palavras-chave:

Demência com corpos de Lewy, Doença de Parkinson, Inibidores de colinesterase, Neurolépticos

Resumo

A demência com corpos de Lewy (DCL) é uma das principais causas de demência, sendo parte de um espectro clínico de doenças com inclusões neuronais denominadas corpos de Lewy, que inclui a doença de Parkinson. Do ponto-de-vista clínico, a DCL caracteriza-se por flutuação cognitiva, alucinações visuais e parkinsonismo espontâneo. O tratamento farmacológico baseia-se no emprego de inibidores de colinesterase, objetivando atenuar os déficits cognitivos e as alterações comportamentais. O emprego de neurolépticos deve ser evitado face à grande sensibilidade desses pacientes aos mesmos

Métricas

Carregando Métricas ...

Downloads

Não há dados estatísticos.

Referências

Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidenced based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-1153.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington: American Psychiatric Association, 1994.

Snowden JS, Neary D, Mann DM. Frontotemporal dementia. Br J Psychiatry 2002; 180: 140-143.

Cummings JL. Alzheimer’s disease. N Engl J Med 2004; 351: 56-67.

Herrera E, Caramelli P, Silveira AS, Nitrini R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002; 16: 103-108.

Takada LT, Caramelli P, Radanovic M, et al. Prevalence of potentially reversible dementias in a dementia outpatient clinic of a tertiary university-affiliated hospital in Brazil. Arq Neuropsiquiatr 2003; 61: 925-929.

McKeith I, Mintzer J, Aarsland D, et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3: 19-28.

Okazaki H, Lipkin LE, Aranson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neurol Pathol Exp Neurol1961; 20: 237-244.

Greicius MD, Geschwind MD, Miller BL. Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry 2002; 72: 691-700.

Aarsland D, Ballard CG, Halliday G. Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 2004; 17: 137-145.

McKeith I, Mosimann UP. Dementia with Lewy bodies and Parkinson’s disease. Parkinsonism Rel Disord 2004; 10: s15-s18.

McKeith I, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.13. McKeith I, Ballard GG, Perry RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54: 1050-1058.

Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125: 391-403.

Stebbins GT, Goetz CG, Carillo MC, et al. Altered cortical visual processing in PD with hallucinations: a fMRI study Neurology 2004; 63: 1409-1416.

Ballard CG, Jacoby R, Del Ser T, et al. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies. Am J Psychiatry 2004; 161: 843-849.

Horimoto Y, Matsumoto M, Nakazawa H, et al. Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson’s disease with dementia. J Neurol Sci 2003; 216: 105-108.

Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2001; 70: 483-488.

Teixeira-Jr AL, Cardoso F. Neuropsiquiatria dos núcleos da base: uma revisão. J Bras Psiquiatr 2004; 53: 153-158.

Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol 2003; 2: 229-237.

Walker Z, Costa DC, Walker RW, et al. Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic ligand. J Neurol Neurosurg Psychiatry 2002; 73: 134-140.

O’Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004; 61: 919-925.

McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036.

Grace J, Daniel S, Stevens T, et al. Long-term use of rivastigmine in patients with dementia with Lewy Bodies: an openlabel trial. Int Psychogeriatr 2001; 13: 199-205.

Samuel W, Caligiuri M, Galasko D, et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies. Int J Geriatr Psychiatry 2000; 15: 794-802.

Aarsland D. Donepezil for cognitive impairment in Parkinson’s disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002; 72: 708-712.

Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson’s disease. N Engl J Med 2004; 351: 2509-2518.

Parkinson Study Group. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med 1999; 340: 757-763.

Wint DP, Okun MS, Fernandez HH. Psychosis in Parkinson’s disease. J Geriatr Psychiatry Neurol 2004; 17: 127-136.

Teixeira-Jr AL, Cardoso F. Tratamento inicial da doença de Parkinson. Revista Neurociências 2004; 12: 146-151.

Downloads

Publicado

2005-03-31

Como Citar

Teixeira-Jr, A. L., & Cardoso, F. (2005). Demência com corpos de Lewy: abordagem clínica e terapêutica. Revista Neurociências, 13(1), 28–33. https://doi.org/10.34024/rnc.2005.v13.8842

Edição

Seção

Artigos de Revisão
##plugins.generic.dates.received## 2019-02-06
##plugins.generic.dates.published## 2005-03-31

Artigos mais lidos pelo mesmo(s) autor(es)

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 10 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.